Back to Search
Start Over
Etirinotecan Pegol (NKTR-102) in Third-line Treatment of Patients With Metastatic or Recurrent Non-Small-cell Lung Cancer: Results of a Phase II Study.
- Source :
- Clinical Lung Cancer; Mar2018, Vol. 19 Issue 2, p157-162, 6p
- Publication Year :
- 2018
Details
- Language :
- English
- ISSN :
- 15257304
- Volume :
- 19
- Issue :
- 2
- Database :
- Complementary Index
- Journal :
- Clinical Lung Cancer
- Publication Type :
- Academic Journal
- Accession number :
- 128123612
- Full Text :
- https://doi.org/10.1016/j.cllc.2017.10.007